This resistance can be reversed through gene silencing or direct inhibition of NAPRT, suggesting that co-administration of NAPRT and NAMPT inhibitors might represent a successful therapy to decrease NAD levels, leading to cancer cell death [12,13]. The gene discussed is NAMPT; the disease is cancer.